Hirsutism future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: ; Rasam Hajiannasab M.D.[2]

Overview

Fluridil is one of the new topical treatment options for hirsutism which is not available yet.

Future or Investigational Therapies

Fluridil (2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl) phenyl]-3-(2,2,2-trifluoroacetylamino)ropanamide) is a new topical antiandrogen agent and has been developed for hyperandrogenic skin syndromes.

A clinical study has shown that a 2% fluridil gel is a safe and effective treatment method of hirsutism and also has no effect on libido or sexual function but Fluridil is not available yet.^[1]

References

↑ Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M (2002). “Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience”. Dermatol Surg. 28 (8): 678–85. PMID 12174057.

Template:WH Template:WS

[pmid12174057-1] Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M (2002). “Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience”. Dermatol Surg. 28 (8): 678–85. PMID 12174057.

[1]

Hirsutism future or investigational therapies

Overview

Future or Investigational Therapies

References

Looking for the patient version?